A Phase II multi-region clinical trial to investigate the safety and efficacy of a lower dose of TTP273 in patients with type 2 diabetes
Latest Information Update: 05 Mar 2018
At a glance
- Drugs TTP 273 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors vTv Therapeutics LLC
Most Recent Events
- 05 Mar 2018 New trial record